Search research articles
Contact Us
Filters
Showing results (11-20 of 57) with videos related to
Page
of 6
Sort By:
Leukemia Research
|
March 21, 2016
Treatment of CD30-positive systemic mastocytosis with brentuximab vedotin
Uma Borate, Amitkumar Mehta, Vishnu Reddy, et al.
Current Hematologic Malignancy Reports
|
January 14, 2022
Multidisciplinary Approach to Older Adults with Hematologic Malignancies-a Paradigm Shift
Sarah A Wall, Erin Stevens, Jennifer Vaughn, et al.
Blood Advances
|
September 21, 2019
Representation of therapy-related myelodysplastic syndrome in clinical trials over the past 20 years
Uma Borate, Brianna A Norris, Abby Statler, et al.
Oncotarget
|
August 6, 2020
Genomic markers of midostaurin drug sensitivity in FLT3 mutated and FLT3 wild-type acute myeloid leukemia patients
Mara W Rosenberg, Kevin Watanabe-Smith, Jeffrey W Tyner, et al.
Expert Review of Hematology
|
August 4, 2022
Burden of chemotherapy in patients with relapsed/refractory acute myeloid leukemia in the United States: a retrospective claims database study
Bhavik J Pandya, Chi-Chang Chen, Catherine B McGuiness, et al.
Advances in Therapy
|
September 6, 2024
Healthcare Utilization and Costs Among Patients with Acute Myeloid Leukemia Receiving Oral Azacitidine Maintenance Therapy Versus No Maintenance: A US Claims Database Study
Uma Borate, Karen Seiter, Ravi Potluri, et al.
International Journal of Hematology
|
September 12, 2014
Clinicopathological and molecular features of myeloid sarcoma as initial presentation of therapy-related myeloid neoplasms: a single institution experience
Deniz Peker, Vishwas Parekh, Ravikumar Paluri, et al.
Cancer Medicine
|
August 28, 2023
Real-world genomic testing and treatment patterns of newly diagnosed adult acute myeloid leukemia patients within a comprehensive health system
John C Byrd, Jennifer L Gatz, Cynthia Lim Louis, et al.
Hematology/Oncology and Stem Cell Therapy
|
March 6, 2019
Allogeneic transplantation outcomes amongst a contemporary cohort of high-risk myelodysplastic syndrome and acute myeloid leukemia patients aged ≥70 years
Curtis Lachowiez, Rachel J Cook, Brandon Hayes-Lattin, et al.
Annals of Hematology
|
February 2, 2023
Venetoclax plus azacitidine compared with intensive chemotherapy as induction for patients with acute myeloid leukemia: retrospective analysis of an electronic medical record database in the United States
Amer M Zeidan, Daniel A Pollyea, Uma Borate, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 57) with videos related to
Sort By:
Page
of 6
Leukemia Research
|
March 21, 2016
Treatment of CD30-positive systemic mastocytosis with brentuximab vedotin
Uma Borate, Amitkumar Mehta, Vishnu Reddy, et al.
Current Hematologic Malignancy Reports
|
January 14, 2022
Multidisciplinary Approach to Older Adults with Hematologic Malignancies-a Paradigm Shift
Sarah A Wall, Erin Stevens, Jennifer Vaughn, et al.
Blood Advances
|
September 21, 2019
Representation of therapy-related myelodysplastic syndrome in clinical trials over the past 20 years
Uma Borate, Brianna A Norris, Abby Statler, et al.
Oncotarget
|
August 6, 2020
Genomic markers of midostaurin drug sensitivity in FLT3 mutated and FLT3 wild-type acute myeloid leukemia patients
Mara W Rosenberg, Kevin Watanabe-Smith, Jeffrey W Tyner, et al.
Expert Review of Hematology
|
August 4, 2022
Burden of chemotherapy in patients with relapsed/refractory acute myeloid leukemia in the United States: a retrospective claims database study
Bhavik J Pandya, Chi-Chang Chen, Catherine B McGuiness, et al.
Advances in Therapy
|
September 6, 2024
Healthcare Utilization and Costs Among Patients with Acute Myeloid Leukemia Receiving Oral Azacitidine Maintenance Therapy Versus No Maintenance: A US Claims Database Study
Uma Borate, Karen Seiter, Ravi Potluri, et al.
International Journal of Hematology
|
September 12, 2014
Clinicopathological and molecular features of myeloid sarcoma as initial presentation of therapy-related myeloid neoplasms: a single institution experience
Deniz Peker, Vishwas Parekh, Ravikumar Paluri, et al.
Cancer Medicine
|
August 28, 2023
Real-world genomic testing and treatment patterns of newly diagnosed adult acute myeloid leukemia patients within a comprehensive health system
John C Byrd, Jennifer L Gatz, Cynthia Lim Louis, et al.
Hematology/Oncology and Stem Cell Therapy
|
March 6, 2019
Allogeneic transplantation outcomes amongst a contemporary cohort of high-risk myelodysplastic syndrome and acute myeloid leukemia patients aged ≥70 years
Curtis Lachowiez, Rachel J Cook, Brandon Hayes-Lattin, et al.
Annals of Hematology
|
February 2, 2023
Venetoclax plus azacitidine compared with intensive chemotherapy as induction for patients with acute myeloid leukemia: retrospective analysis of an electronic medical record database in the United States
Amer M Zeidan, Daniel A Pollyea, Uma Borate, et al.
Page
of 6